Skip to main content
Baxdela 300 mg/10.5mL injection, powder, lyophilized, for solution by Melinta Therapeutics, LLC
Baxdela, 300 mg/10.5mL, injection, powder, lyophilized, for solution Drug class: Fluoroquinolone Antibacterial. Available on prescription only. Listed by Melinta Therapeutics, LLC.
Prescription only

Baxdela

delafloxacin meglumine

Listed by Melinta Therapeutics, LLC

Strength
300 mg/10.5mL
Form
Injection, Powder, Lyophilized, For Solution
Route
Intravenous
Class
Fluoroquinolone Antibacterial

What it contains

  • Delafloxacin Meglumine 300 mg/10.5mL

FDA record

Dosage form Injection, Powder, Lyophilized, For Solution
Route Intravenous
Drug class Fluoroquinolone Antibacterial
Approval route NDA — original brand approval
NDC code 70842-102
FDA application NDA208611
RxNorm concept 1927667
Package sizes listed 1
Marketed since June 2017

Other products containing Delafloxacin Meglumine

See all

Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.

Baxdela

delafloxacin meglumine

Strength
450 mg/1
Form
Tablet
Class
Fluoroquinolone Antibacterial
Rx only

Melinta Therapeutics, LLC

Not stocked by us — reference only

Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.